Company research
NewcelX Ltd.
CIK 1783036Updated Sep 25, 2026
SecurityNCEL · NASDAQ · equity
Historical securities (2)
NLSP · OTC · equity · closed Oct 30, 2025NLSPW · NASDAQ · warrant · closed Oct 30, 2025Name history
NLS Pharmaceutics Ltd. · through Oct 30, 2025
NCEL price & chart
Loading TradingView…
NASDAQ:NCEL on TradingView ↗In the news
NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd. News provided by NewcelX Ltd. Nov 03, 2025, 08:25 ET Share this article Share to X Share this article Share to X ZURICH , Nov. 3, 2025 /PRNewswire/ -- NewcelX Ltd. (Nasdaq: NCEL ) ("NewcelX ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 11,445,000Source | 2,233,125Source | 1,846,641Source | 9,276,643Source |
| Property, Plant and Equipment, NetUSD | 95,000Source | 7,290Source | 6,694Source | 18,102Source |
| GoodwillUSD | 1,731,000Source | — | — | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,201,000Source | 1,665,395Source | 897,680Source | 8,948,400Source |
| Assets, CurrentUSD | 3,182,000Source | 2,225,552Source | 1,823,062Source | 9,246,398Source |
| Prepaid Expense and Other Assets, CurrentUSD | 981,000Source | 560,157Source | 925,382Source | 297,998Source |
| Other Assets, NoncurrentUSD | — | 283Source | 16,885Source | 12,143Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 4,195,000Source | 826,764Source | 10,680,204Source | 5,995,804Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | 2,740,958Source | — | — |
| Common Stock, Value, IssuedUSD | 291,000Source | 166,353Source | 733,413Source | 668,555Source |
| Additional Paid in CapitalUSD | 93,691,000Source | 72,820,671Source | 61,029,437Source | 60,864,530Source |
| Retained Earnings (Accumulated Deficit)USD | -84,891,000Source | -74,430,474Source | -70,373,484Source | -58,201,455Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | — | 108,853Source | -158,071Source | -50,791Source |
| Stockholders' Equity Attributable to ParentUSD | 7,250,000Source | 1,406,361Source | -8,833,563Source | 3,280,839Source |
| Liabilities and EquityUSD | 11,445,000Source | 2,233,125Source | 1,846,641Source | 9,276,643Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 4,195,000Source | 826,764Source | 7,919,550Source | 3,359,713Source |
| Accounts Payable, CurrentUSD | — | 515,486Source | 4,633,534Source | 2,373,276Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 880,000Source | — | 1,652,270Source | 986,437Source |
| Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after TaxUSD | — | 108,853Source | -158,073Source | — |
| Deferred Revenue, CurrentUSD | — | — | — | 264,997Source |
| Deferred Revenue, NoncurrentUSD | — | — | 2,499,969Source | 2,499,969Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -16,495,680Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 765,000Source | — | — | 22,730Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | — | -118,047Source | 2,260,258Source | 636,263Source |
| Deferred Income Tax Expense (Benefit)USD | — | 270,668Source | 852,486Source | 1,004,681Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -2,766,000Source | -4,267,884Source | -9,684,466Source | -13,879,371Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | -1,708,000Source | — | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 1,700,000Source | -3,917Source | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 8,000Source | 3,917Source | — | — |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 2,629,000Source | 5,039,516Source | 1,633,746Source | 17,396,669Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 1,551,000Source | 767,715Source | -8,050,720Source | 3,517,198Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,201,000Source | 1,665,395Source | 897,680Source | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 20,000Source | 467Source | 145,153Source | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -12,000Source | — | — | -100Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 765,000Source | 125,644Source | 164,906Source | — |
| DepreciationUSD | 55,000Source | 3,321Source | 11,408Source | 11,408Source |
| General and Administrative ExpenseUSD | 1,348,000Source | 3,214,224Source | 5,898,775Source | 6,505,721Source |
| GoodwillUSD | 1,731,000Source | — | — | — |
| Insured Event, Gain (Loss)USD | — | -109,650Source | — | — |
| InterestExpenseNonoperatingUSD | — | 45,054Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -8,300,000Source | -1,980,810Source | -12,172,029Source | -16,495,680Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 8,300,000Source | -4,056,990Source | — | — |
| Nonoperating Income (Expense)USD | -5,738,000Source | 2,399,303Source | — | — |
| Operating Costs and ExpensesUSD | — | 10,000,000Source | — | — |
| Operating ExpensesUSD | — | 4,380,113Source | 11,807,063Source | 15,482,364Source |
| Operating Lease, ExpenseUSD | 92,000Source | — | — | — |
| Other Nonoperating Income (Expense)USD | -99,000Source | 49,351Source | -219,812Source | 10,045Source |
| Pension Cost (Reversal of Cost)USD | — | 6,239Source | 59,526Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | 1,911,513Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 23,692Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -2,562,000Source | -4,380,113Source | -11,807,063Source | -15,482,364Source |
| Other Nonoperating Income (Expense)USD | -99,000Source | 49,351Source | -219,812Source | 10,045Source |
| Net Income (Loss) Attributable to ParentUSD | -8,300,000Source | -1,980,810Source | -12,172,029Source | -16,495,680Source |
| Earnings Per Share, BasicUSD per share | 2.16Source | -2.63Source | -0.32Source | -0.84Source |
| Earnings Per Share, DilutedUSD per share | 2.16Source | -2.63Source | -0.32Source | -0.84Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 3,843,984Source | 1,543,283Source | 38,176,020Source | 19,682,643Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 3,843,984Source | 1,543,283Source | 38,176,020Source | 19,682,643Source |
| Interest Expense (non-operating)USD | — | 45,054Source | — | — |
| Additional Financial Items | ||||
| Depreciation, Depletion and Amortization, NonproductionUSD | 55,000Source | — | — | — |
| General and Administrative ExpenseUSD | 1,348,000Source | 3,214,224Source | 5,898,775Source | 6,505,721Source |
| Income (Loss) Attributable to Parent, before TaxUSD | -8,300,000Source | — | — | — |
| Interest ExpenseUSD | — | — | 119,920Source | — |
| Interest Expense, DebtUSD | — | — | — | 95,211Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 8,300,000Source | -4,056,990Source | — | — |
| Nonoperating Income (Expense)USD | -5,738,000Source | 2,399,303Source | — | — |
| Operating Costs and ExpensesUSD | — | 10,000,000Source | — | — |
| Operating ExpensesUSD | — | 4,380,113Source | 11,807,063Source | 15,482,364Source |
| Operating Lease, ExpenseUSD | 92,000Source | — | — | — |
| Other ExpensesUSD | 88,000Source | 321,000Source | — | — |
| Other Operating IncomeUSD | — | — | — | 16,300,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | 2,076,180Source | — | — |
| Research and Development ExpenseUSD | 1,126,000Source | 422,051Source | 5,908,288Source | 8,976,643Source |